Today we are going to look at Instem plc (LON:INS) to see whether it might be an attractive investment prospect. To be precise, we'll consider its Return On Capital Employed (ROCE), as that will ...

Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility of prices, but whether you will suffer a permanent loss of capital.' When we ...

CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--Instem, a leading provider of IT solutions to the global early development healthcare market, is pleased to announce that NOTOCORD ...

Instem, a global leader in IT solutions for life sciences, has announced the launch of its new Non-GLP Pathology Module for Provantis, the market share-leading in vivo preclinical study management ...

(RTTNews) - IT solutions provider Instem Plc (INS.L) announced Wednesday that it has agreed to be acquired by Ichor Management Ltd., controlled by funds managed by investment firm ARCHIMED, in ...

BOSTON & STAFFORDSHIRE, England, April 17, 2025--(BUSINESS WIRE)--Following the FDA’s recent announcement expanding flexibility in preclinical submission evidence, Instem is reaffirming its role as ...

Instem, a leading provider of SaaS solutions for preclinical R&D, today announced the appointment of Szczepan Baran, VMD, MS, as Chief Scientific Officer. In the role, Szczepan will lead scientific ...

Instem, a global leader in SaaS solutions for life sciences R&D, today announced the official opening of its new global headquarters in Boston, Massachusetts, strategically located in one of the world ...

Logos is headquartered in London with staff located both in the United Kingdom and the United States, Logos is well known for providing its customers with quality products that are developed following ...

BENGALURU: In order to prevent long lasting immune reaction of damaged cells in body, known as sterile inflammation leading to osteoarthritis, rheumatoid arthritis and fibrosis, a team of researchers ...

Following the FDA's recent announcement expanding flexibility in preclinical submission evidence, Instem is reaffirming its role as the industry's trusted provider of an end-to-end preclinical ...